 
            
        This is an Application Brief and does not contain a detailed Experimental section.
This application brief highlights the scaling-up of beta-blockers in TFA.
Compounds used in this study:
1. Nadolol (100 mg/mL)
2. Metoprolol (100 mg/mL)
3. Propranolol (50 mg/mL)
 
            
        | Column: | SunFire C18 4.6 x 50 mm, 5 μm (p/n: 186002557) 19 x 50 mm, 5 μm (p/n: 186002566) | 
| Mobile phase A: | 0.1% TFA in Water | 
| Mobile phase B: | 0.1% TFA in ACN | 
| Temperature: | Ambient | 
| Detection: | UV @ 260 nm | 
| Instrument: | AutoPurification System | 
 
            
         
            
        WA41886, May 2005